Anthony Rodgers
#111,184
Most Influential Person Now
Researcher
Anthony Rodgers's AcademicInfluence.com Rankings
Anthony Rodgersengineering Degrees
Engineering
#3214
World Rank
#4254
Historical Rank
Electrical Engineering
#688
World Rank
#752
Historical Rank
Anthony Rodgerscomputer-science Degrees
Computer Science
#4204
World Rank
#4424
Historical Rank
Computational Linguistics
#358
World Rank
#363
Historical Rank
Machine Learning
#754
World Rank
#764
Historical Rank
Artificial Intelligence
#963
World Rank
#980
Historical Rank
Download Badge
Engineering Computer Science
Anthony Rodgers's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Anthony Rodgers Influential?
(Suggest an Edit or Addition)Anthony Rodgers's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. (2008) (5018)
- Selected major risk factors and global and regional burden of disease (2002) (3830)
- Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack (2001) (2412)
- Comparative quantification of health risks. Global and regional burden of disease attributable to selected major risk factors. Volume 1. (2004) (2251)
- Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials (2000) (2202)
- Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis (2016) (2132)
- Global burden of blood-pressure-related disease, 2001 (2008) (1967)
- Worldwide access to treatment for end-stage kidney disease: a systematic review (2015) (1375)
- Interpretation of the evidence for the efficacy and safety of statin therapy (2016) (1290)
- Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial (2000) (962)
- Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis (2016) (826)
- Mobile phone-based interventions for smoking cessation. (2012) (778)
- Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging (2005) (757)
- Comparative quantification of health risks: Conceptual framework and methodological issues (2003) (742)
- Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial (2011) (729)
- Blood Pressure and Stroke: An Overview of Published Reviews (2004) (721)
- Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk (2003) (623)
- Rethinking the “Diseases of Affluence” Paradigm: Global Patterns of Nutritional Risks in Relation to Economic Development (2005) (587)
- 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. (1999) (557)
- Blood pressure, cholesterol, and stroke in eastern Asia (1998) (553)
- Blood pressure and cardiovascular disease in the Asia Pacific region (2003) (550)
- Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease: A Randomized Clinical Trial. (2015) (544)
- Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis. (2016) (531)
- Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk (2005) (519)
- Estimates of global and regional potential health gains from reducing multiple major risk factors (2003) (510)
- Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. (2014) (503)
- Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial (2005) (408)
- Electrochemically controlled drug delivery based on intrinsically conducting polymers. (2010) (383)
- Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. (2003) (382)
- Comparative Quantification of Mortality and Burden of Disease Attributable to Selected Risk Factors (2006) (366)
- Hypertension (1942) (365)
- Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs (2007) (357)
- Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. (2004) (356)
- Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. (2013) (348)
- Honey as a topical treatment for wounds. (2008) (344)
- Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden (2006) (322)
- Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial (2006) (308)
- The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. (2003) (301)
- Energy expended playing video console games: an opportunity to increase children's physical activity? (2007) (288)
- Blood pressure and risk of stroke in patients with cerebrovascular disease (1996) (276)
- Effects of active video games on body composition: a randomized controlled trial. (2011) (270)
- Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea: A Systematic Review and Meta-analysis (2017) (267)
- Distribution of Major Health Risks: Findings from the Global Burden of Disease Study (2004) (260)
- Effects of price discounts and tailored nutrition education on supermarket purchases: a randomized controlled trial. (2010) (257)
- Mobile phone-based interventions for smoking cessation. (2016) (246)
- Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis (2013) (246)
- Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. (1997) (244)
- Couch potatoes to jumping beans: A pilot study of the effect of active video games on physical activity in children (2008) (236)
- International Physical Activity Questionnaire (IPAQ) and New Zealand Physical Activity Questionnaire (NZPAQ): A doubly labelled water validation (2007) (213)
- Mobile phone text messaging and app-based interventions for smoking cessation. (2019) (206)
- Effectiveness of monetary incentives in modifying dietary behavior:a review of randomized, controlled trials. (2006) (202)
- A Theory-Based Video Messaging Mobile Phone Intervention for Smoking Cessation: Randomized Controlled Trial (2011) (200)
- Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. (2004) (198)
- The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. (1993) (186)
- Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON (2016) (185)
- Cardiovascular risk factors at age 30 following pre-term birth. (2007) (184)
- A Multimedia Mobile Phone–Based Youth Smoking Cessation Intervention: Findings From Content Development and Piloting Studies (2008) (183)
- Blood pressure and stroke: an overview of published reviews. (2004) (182)
- Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) (181)
- Txt2stop: a pilot randomised controlled trial of mobile phone-based smoking cessation support (2009) (178)
- Cardiovascular risk prediction tools for populations in Asia (2007) (175)
- Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. (2005) (173)
- Randomized clinical trial of honey‐impregnated dressings for venous leg ulcers (2007) (172)
- Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial (2005) (165)
- Reducing the global burden of blood pressure-related cardiovascular disease. (2000) (165)
- Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis (2015) (164)
- MEMO—A Mobile Phone Depression Prevention Intervention for Adolescents: Development Process and Postprogram Findings on Acceptability From a Randomized Controlled Trial (2012) (161)
- Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus (2016) (161)
- Blood pressure, antihypertensive treatment and stroke risk. (1994) (160)
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control. (2016) (160)
- Smoking cessation using mobile phone text messaging is as effective in Maori as non-Maori. (2005) (156)
- Blood Pressure Indices and Cardiovascular Disease in the Asia Pacific Region: A Pooled Analysis (2003) (155)
- An International Randomised Placebo-Controlled Trial of a Four-Component Combination Pill (“Polypill”) in People with Raised Cardiovascular Risk (2011) (154)
- Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levels (2006) (154)
- A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk (2015) (147)
- Smoking and Elevated Blood Pressure Are the Most Important Risk Factors for Subarachnoid Hemorrhage in the Asia-Pacific Region: An Overview of 26 Cohorts Involving 306 620 Participants (2005) (141)
- The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop (2012) (140)
- Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation (2001) (140)
- Redefining Blood-Pressure Targets--SPRINT Starts the Marathon. (2015) (139)
- Reducing Attention Deficits After Stroke Using Attention Process Training: A Randomized Controlled Trial (2009) (137)
- Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care (2014) (132)
- The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults (2004) (132)
- Potential health gains from reducing multiple risk factors (2004) (126)
- Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial (2007) (122)
- Sodium‐Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis (2020) (120)
- A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery (2000) (118)
- The effects of antihypertensive treatment on vascular disease: Reappraisal of the evidence in 1994 (1993) (117)
- Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies (2018) (115)
- Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial (2018) (109)
- Joint Effects of Systolic Blood Pressure and Serum Cholesterol on Cardiovascular Disease in the Asia Pacific Region (2005) (103)
- Cohort profile: the Asia Pacific Cohort Studies Collaboration. (2006) (101)
- Chitosan for overweight or obesity. (2005) (99)
- Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1998) (99)
- Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis (2012) (98)
- Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries. (2016) (98)
- Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus (2012) (97)
- The association between resting heart rate, cardiovascular disease and mortality: evidence from 112,680 men and women in 12 cohorts (2014) (93)
- Body mass index and risk of diabetes mellitus in the Asia-Pacific region. (2006) (93)
- Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack (2005) (89)
- Conspicuity and bicycle crashes: preliminary findings of the Taupo Bicycle Study (2008) (88)
- Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants. (2020) (85)
- Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease. (2015) (84)
- Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. (2000) (81)
- Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. Commentary (2006) (80)
- Effect of chitosan on weight loss in overweight and obese individuals: a systematic review of randomized controlled trials (2005) (79)
- The Efficacy and Tolerability of ‘Polypills’: Meta-Analysis of Randomised Controlled Trials (2012) (78)
- Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes (2016) (78)
- Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review (2017) (78)
- Applying a 3.0 transformation framework to guide large-scale health system reform. (2014) (73)
- Do effects of price discounts and nutrition education on food purchases vary by ethnicity, income and education? Results from a randomised, controlled trial (2011) (72)
- Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges. (2013) (72)
- Blood pressure and coronary heart disease: a review of the evidence. (2002) (69)
- The Epidemiological Association between Blood Pressure and Stroke: Implications for Primary and Secondary Prevention (1994) (67)
- Nutrition and the burden of disease in New Zealand: 1997–2011 (2005) (65)
- Prevalence trends tell us what did not precipitate the US obesity epidemic. (2018) (65)
- Psychological functioning and health‐related quality of life in adulthood after preterm birth (2007) (63)
- Systematic Underestimation of Treatment Effects as a Result of Diagnostic Test Inaccuracy: Implications for the Interpretation and Design of Thromboprophylaxis Trials (1995) (63)
- A cure for cardiovascular disease? (2003) (62)
- Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial (2010) (62)
- Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021) (60)
- Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data (2018) (59)
- A randomised controlled trial of a consumer-focused e-health strategy for cardiovascular risk management in primary care: the Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) study protocol (2014) (58)
- Pre-cessation nicotine replacement therapy: pragmatic randomized trial. (2010) (58)
- Randomised studies of income supplementation: a lost opportunity to assess health outcomes. (1999) (57)
- Mobile phone-based interventions for smoking cessation. (2009) (57)
- Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and Europe (2012) (56)
- Determinants of cardiovascualar disease in the Asia Pacific region: protocol for a collaborative overview of cohort studies (1999) (56)
- Long term effects of antenatal betamethasone on lung function: 30 year follow up of a randomised controlled trial (2006) (55)
- Will screening individuals at high risk of cardiovascular events deliver large benefits? Yes (2008) (53)
- Hypertension—time to move on (2005) (51)
- Mortality and burden of disease attributable to individual risk factors (2004) (51)
- Peak Bone Mass After Exposure to Antenatal Betamethasone and Prematurity: Follow‐up of a Randomized Controlled Trial (2006) (49)
- Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region (2004) (49)
- Chitosan for overweight or obesity. (2008) (49)
- Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial (2012) (49)
- Leg ulceration and perceived health: a population based case-control study. (2004) (49)
- Maintaining confidentiality of interim data to enhance trial integrity and credibility (2008) (49)
- Mortality after hip fracture: regional variations in New Zealand. (1999) (48)
- Feasibility, design and conduct of a pragmatic randomized controlled trial to reduce overweight and obesity in children: The electronic games to aid motivation to exercise (eGAME) study (2009) (48)
- Random errors in the measurement of 10 cardiovascular risk factors (2004) (47)
- The effects of diabetes mellitus on the risks of major cardiovascular diseases and death in the Asia-Pacific region (Journal article) (2003) (47)
- The Growing Burden of Risk from High Blood Pressure, Cholesterol, and Bodyweight (2006) (47)
- Development of a Controlled Release System for Risperidone Using Polypyrrole: Mechanistic Studies (2010) (47)
- Repeated intranasal ketamine for treatment-resistant depression – the way to go? Results from a pilot randomised controlled trial (2018) (47)
- Comparison of a morning polypill, evening polypill and individual pills on LDL-cholesterol, ambulatory blood pressure and adherence in high-risk patients; a randomized crossover trial. (2015) (46)
- Blood Pressure at 6 Years of Age After Prenatal Exposure to Betamethasone: Follow-up Results of a Randomized, Controlled Trial (2004) (45)
- Blood pressure lowering for the secondary prevention of myocardial infarction and stroke. (1997) (44)
- Vegetable and fruit intake and mortality from chronic disease in New Zealand (2006) (43)
- Estimating Energy Expenditure With the RT3 Triaxial Accelerometer (2009) (43)
- No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: A randomized trial of 2,649 patients (2000) (43)
- IMProving Adherence using Combination Therapy (IMPACT): design and protocol of a randomised controlled trial in primary care. (2011) (43)
- Evaluation of physical properties and performance over time of an actuating polypyrrole based drug delivery system (2010) (42)
- Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis (2021) (42)
- Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: a systematic review and meta-analysis of randomized controlled trials. (2019) (41)
- Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON (2017) (41)
- MEMO: an mHealth intervention to prevent the onset of depression in adolescents a double‐blind, randomised, placebo‐controlled trial (2017) (41)
- Mobile phone text-messaging interventions aimed to prevent cardiovascular diseases (Text2PreventCVD): systematic review and individual patient data meta-analysis (2019) (41)
- Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk (2010) (41)
- Strategies to promote healthier food purchases: a pilot supermarket intervention study (2007) (40)
- Responsiveness of generic and disease‐specific health‐related quality of life instruments to venous ulcer healing (2010) (40)
- Cyclists' attitudes toward policies encouraging bicycle travel: findings from the Taupo Bicycle Study in New Zealand. (2010) (40)
- Cost-effectiveness of a text message programme for the prevention of recurrent cardiovascular events (2017) (40)
- The role of lifestyle risk factors on mortality from colorectal cancer in populations of the Asia-Pacific region. (2007) (39)
- Efficacy and Safety of Quarter-Dose Blood Pressure–Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2017) (38)
- Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial (2019) (37)
- Subarachnoid haemorrhage occurrence exhibits a temporal pattern – evidence from meta‐analysis (2002) (36)
- Does improved access and greater choice of nicotine replacement therapy affect smoking cessation success? Findings from a randomized controlled trial. (2011) (36)
- Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials (2018) (35)
- The occurrence of leg ulcers in Auckland: results of a population-based study. (2002) (35)
- Associations between body mass index and the risk of renal events in patients with type 2 diabetes (2018) (34)
- Leg ulcers in New Zealand: age at onset, recurrence and provision of care in an urban population. (2002) (34)
- Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk. (2005) (34)
- Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy: a systematic review and meta-analysis of randomized controlled trials. (2019) (34)
- Polypill treatments for cardiovascular diseases (2016) (33)
- The emerging role of induced hypothermia in the management of acute stroke (2002) (33)
- Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial (2010) (33)
- Blood pressure and the global burden of cardiovascular disease. (1999) (32)
- Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE Collaboration. (2013) (32)
- Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35–74 Years: The Cardiovascular Disease Policy Model (2016) (31)
- The emerging role of therapeutic hypothermia in acute stroke (2003) (31)
- The impact of modifiable risk factors on mortality from prostate cancer in populations of the Asia-Pacific region. (2007) (29)
- Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials (2019) (29)
- Elevated total cholesterol: its prevalence and population attributable fraction for mortality from coronary heart disease and ischaemic stroke in the Asia-Pacific region (2008) (29)
- Effects of continuous positive airway pressure on depression and anxiety symptoms in patients with obstructive sleep apnoea: results from the sleep apnoea cardiovascular Endpoint randomised trial and meta-analysis (2019) (28)
- Less salt does not necessarily mean less taste (1999) (28)
- The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program (2019) (27)
- Regression to the mean of repeated ambulatory blood pressure monitoring in five studies (2019) (26)
- Regional variation in the incidence of hip fracture in New Zealand. (1997) (26)
- Collaborative overview (‘Meta-Analysis’) of Prospective Observational Studies of the Associations of Usual Blood Pressure and Usual Cholesterol Levels with Common Causes of Death: Protocol for the Second Cycle of the Prospective Studies Collaboration (1999) (26)
- Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study (2019) (26)
- Causal decomposition of summary measures of population health. (2002) (26)
- Effect of text messaging on depression in patients with coronary heart disease: a substudy analysis from the TEXT ME randomised controlled trial (2019) (25)
- Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial. (1994) (25)
- Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis (2021) (25)
- Ethnic disparities in nutrition-related mortality in New Zealand: 1997-2011. (2006) (25)
- Mortality attributable to higher-than-optimal body mass index in New Zealand (2005) (24)
- Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk (2014) (24)
- The lowering of blood pressure after stroke (2001) (24)
- Obesity and health-related quality of life: results from a weight loss trial. (2004) (23)
- The effect of active video games by ethnicity, sex and fitness: subgroup analysis from a randomised controlled trial (2014) (23)
- Does capture‐recapture analysis provide more reliable estimates of the incidence and prevalence of leg ulcers in the community? (2002) (23)
- Primary and secondary prevention of stroke. (1996) (23)
- Developing nutrition education resources for a multi-ethnic population in New Zealand. (2009) (22)
- The Effect of a Cardiovascular Polypill Strategy on Pill Burden. (2015) (22)
- Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty (Cochrane Review) (2003) (22)
- Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States. (2019) (21)
- The emerging role of therapeutic hypothermia in stroke .[In response to Olsen TS, Weber UJ,Kammersgaard LP]. Therapeutic hypothermia for acute stroke (2003) (21)
- Blood Pressure Lowering for the Prevention of Cognitive Decline in Patients with Cerebrovascular Disease (1997) (21)
- Fixed-dose combinations for hypertension (2018) (21)
- Leg ulceration as a long-term complication of deep vein thrombosis. (2003) (20)
- 1E-4 Cardiovascular risk factors at age 30 following preterm birth (2007) (20)
- Pharmacological thromboprophylaxis in hip and knee surgery: a survey of New Zealand orthopaedic surgeons. (1994) (19)
- The UK breast cancer screening programme: an expensive mistake. (1990) (19)
- Screening and intervention for alcohol problems among patients admitted following unintentional injury: a missed opportunity? (2007) (18)
- Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial. (2019) (18)
- BLOOD PRESSURE LOWERING IN PATIENTS WITH CEREBROVASCULAR DISEASE: RESULTS OF THE PROGRESS (PERINDOPRIL PROTECTION AGAINST RECURRENT STROKE STUDY) PILOT PHASE (1996) (18)
- Two‐drug fixed‐dose combinations of blood pressure‐lowering drugs as WHO essential medicines: An overview of efficacy, safety, and cost (2020) (18)
- Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial (2020) (17)
- Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial (2019) (17)
- An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trial (2014) (17)
- Text2PreventCVD: protocol for a systematic review and individual participant data meta-analysis of text message-based interventions for the prevention of cardiovascular diseases (2016) (17)
- Design Considerations in Development of a Mobile Health Intervention Program: The TEXT ME and TEXTMEDS Experience (2016) (16)
- Impact of cigarette smoking on the relationship between body mass index and coronary heart disease: a pooled analysis of 3264 stroke and 2706 CHD events in 378579 individuals in the Asia Pacific region (2009) (16)
- Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial. (2018) (16)
- Process evaluation of the impact and acceptability of a polypill for prevention of cardiovascular disease (2015) (16)
- Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease (2016) (15)
- Recruiting equal numbers of indigenous and non-indigenous participants to a ‘polypill’ randomized trial (2013) (15)
- Cumulative in-trial and post-trial effects of blood pressure and lipid lowering: systematic review and meta-analysis (2017) (15)
- Attitudes and Practices of New Zealand Anaesthetists with Regard to Epidural and Subarachnoid Anaesthesia (1996) (15)
- Estimated cardiovascular relative risk reduction from fixed-dose combination pill (polypill) treatment in a wide range of patients with a moderate risk of cardiovascular disease (2016) (14)
- A digital health intervention for cardiovascular disease management in primary care (CONNECT) randomized controlled trial (2020) (14)
- Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India (2018) (14)
- Venous ulcer management in New Zealand: usual care versus guideline recommendations. (2009) (14)
- Ethnic disparities in risk factors for stroke: what are the implications? (2004) (14)
- Aspirin for primary prevention: yes or no? (2010) (14)
- The associations of diastolic blood pressure with the risk of stroke in Western and Eastern populations. (1999) (14)
- The PROGRESS trial three years later: time for more action, less distraction (2004) (14)
- The Evening versus Morning Polypill Utilization Study: the TEMPUS rationale and design (2014) (14)
- More Versus Less Blood Pressure Lowering: An Update. (2016) (13)
- The Potential Effectiveness of COVID-Related Smoking Cessation Messages in Three Countries (2021) (13)
- Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial. (2020) (13)
- Income, health, and the National Lottery (2001) (13)
- National drug policy reform for noncommunicable diseases in low-resource countries: an example from Bangladesh (2016) (13)
- TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol. (2014) (13)
- Changing patterns of pharmacological thromboprophylaxis use by orthopaedic surgeons in New Zealand (2002) (12)
- Regional anaesthesia reduces perioperative mortality: results from an overview of randomised trials (2000) (12)
- Blood pressure lowering for the primary and secondary prevention of coronary and cerebrovascular disease. (1995) (12)
- Conceptual framework and methodological issues (2004) (12)
- Perindopril-based blood pressure lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or TIA (130th American Neurological Association) (2005) (11)
- Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension (2022) (11)
- Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (2021) (11)
- Prevention of cardiovascular diseases in developing countries: agenda for action: statement from a WHO-ISH meeting in Beijing (1999) (11)
- A digital health intervention for cardiovascular disease management in primary care (CONNECT) randomized controlled trial. (2020) (11)
- Preferences for Tobacco Cessation Information and Support During Covid-19 (2020) (10)
- Polypyrrole Film as a Drug Delivery System for the Controlled Release of Risperidone (2009) (10)
- An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: protocol for a cluster randomized controlled trial (2015) (10)
- Use of electronic sales data to tailor nutrition education resources for an ethnically diverse population. (2010) (10)
- Prospective meta-analysis protocol on randomised trials of renin–angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension (2021) (10)
- The impact of Coronavirus disease 2019 (COVID‐19) pandemic on migraine disorder (2021) (9)
- Conclusions and directions for future research (2004) (9)
- Polypill: Progress and Challenges to Global Use—Update on the Trials and Policy Implementation (2015) (9)
- Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof study (2022) (8)
- Intensive glucose‐lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial (2019) (8)
- Blood pressure and the burden of coronary heart disease (2009) (8)
- Forty years of randomised trials in the New Zealand Medical Journal. (1996) (8)
- Clinical trials in NZ: does anybody know what's going on? (2002) (8)
- Chitosan for overweight or obesity (Review) (2008) (8)
- Evaluating the costs and benefits of using combination therapies (2014) (7)
- Can we eliminate inequalities in coronary disease? Absolutely (2008) (7)
- Cardiovascular mortality attributable to high blood cholesterol in New Zealand (2006) (7)
- Lawes et al Blood Pressure and Stroke : An Overview 777 (2004) (7)
- PROGRESS – perindopril protection against recurrent stroke study: status in July 1996 (1996) (7)
- Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis (2022) (7)
- Effects of blood pressure-lowering drugs in heart failure: a systematic review and meta-analysis of randomized controlled trials. (2019) (6)
- Ultra-low-dose quadruple combination blood pressure–lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol (2020) (6)
- Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical Trial (2022) (6)
- Erratum: Reducing Premature Cardiovascular Morbidity and Mortality in People with Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease (Glob Heart (2015)10 (99-110)) (2015) (6)
- Antihypertensive Agents and Stroke Prevention (1994) (6)
- Intensive blood pressure lowering – Authors' reply (2016) (6)
- Clinical trials in New Zealand--treading water in the knowledge wave? (2005) (6)
- Pharmacokinetics of Rosuvastatin: A Systematic Review of Randomised Controlled Trials in Healthy Adults (2021) (6)
- Regression to the mean in home blood pressure: Analyses of the BP GUIDE study (2020) (5)
- Blood pressure lowering for the prevention of cognitive decline in patients with cerebrovascular disease. PROGRESS Management Committee. Perindopril Protection Against Recurrent Stroke Study. (1997) (5)
- Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis (2022) (5)
- Guideline for the diagnosis and management of hypertension in adults — 2016 (2017) (5)
- A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countries. (2003) (5)
- Cholestrol, coronary heart disease, and stroke in the Asia Pacific region (2007) (2007) (5)
- Randomized clinical trial Randomized clinical trial of honey-impregnated dressings for venous leg ulcers (2008) (4)
- Evaluating factors influencing the delivery and outcomes of an incentive-based behaviour change strategy targeting child obesity: protocol for a qualitative process and impact evaluation (2016) (4)
- PEP trial - Reply (2000) (4)
- Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial. (2023) (4)
- Lost in translation: the gap between what we know and what we do about cardiovascular disease (2016) (4)
- Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis (2022) (4)
- Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes (2009) (4)
- Cardiovascular treatment gaps: closing, but slowly. (2009) (4)
- Non‐steroidal anti‐inflammatory agents for the prevention of heterotopic bone formation after hip surgery (2000) (3)
- Less salt in bread: a cost-effective way to reduce New Zealand population blood pressure levels. (2003) (3)
- Comments on Cooper et al.’s review on strategies to mitigate dissociative and psychotomimetic effects from ketamine when used as a fast-acting antidepressant (2017) (3)
- Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials (2017) (3)
- Systematic reviews of antihypertensive drugs: A review of publication trends, characteristics, and quality (2021) (3)
- Antiplatelet therapy and the prevention of thrombosis. (1996) (3)
- Does splitting a tablet obtain the accurate dose? (2019) (3)
- An electronic decision support‐based complex intervention to improve management of cardiovascular risk in primary health care: a cluster randomised trial (INTEGRATE) (2021) (3)
- Edinburgh trial of screening for breast cancer (1990) (3)
- Prevention: Coronary artery calcium and polypill therapy (2014) (3)
- Does Co-administration of Antihypertensive Drugs and Statins Alter Their Efficacy and Safety? A Systematic Review and Meta-analysis of Randomized Controlled Trials. (2019) (3)
- Impact of switching to polypill based therapy by baseline potency of medication: Post-hoc analysis of the SPACE Collaboration dataset. (2017) (3)
- Universal Depresion Prevention via Mobile Phones (2012) (3)
- Blood pressure and the risk of recurrent vascular disease (1998) (3)
- 06 The pulmonary embolism prevention (PEP) trial: effects of low-dose aspirin on major vascular events in hip fracture surgical patients (1999) (2)
- Need for an updated overview to assess the benefits of epidurals. (2003) (2)
- Breast cancer screening: the current position (1991) (2)
- The 2016 Joint European Prevention Guidelines and the uses of polypills: Time to update the evidence (2019) (2)
- Breast screening in women aged 65-79. (1991) (2)
- Questionable Conclusions Regarding Blood Pressure End Points. (2018) (2)
- INTegrated Electronic General practice support tool, phaRmacy led intervention And combination Therapy Evaluation trial (INTEGRATE). (2015) (2)
- Response to 'SPRINT in context: meta-analysis of trials with baseline normotension and low levels of previous cardiovascular disease'. (2018) (2)
- Redefining blood pressure targets (2017) (2)
- Impact of polypill based therapy on SBP and LDL cholesterol control stratified by potency of baseline regimen (2015) (2)
- Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical Trial. (2022) (2)
- Comparative cost-effectiveness of conservative or intensive blood pressure treatment guidelines in adults aged 35-74 years : the CVD Policy Model (2016) (2)
- Polygenic risk scores predict diabetic complications and their response to therapy (2019) (2)
- Effectiveness of an Integrated Responsive Web Application for Cardiovascular Disease Management in Primary Care: 1 Year Multicenter, Open-Label Randomized Controlled Trial (2020) (2)
- Pragmatism and perfection in the prevention of cardiovascular disease (2007) (2)
- Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With Diabetes. (2022) (2)
- Low-dose aspirin prevented deep venous thrombosis and pulmonary embolism after surgery for hip fracture (2000) (2)
- Quality of systematic reviews supporting the 2017 ACC/AHA and 2018 ESC/ESH guidelines for the management of hypertension (2021) (2)
- Reduced efficacy of blood pressure lowering drugs in the presence of diabetes mellitus—results from the TRIUMPH randomised controlled trial (2022) (1)
- messagingcessation using mobile phone text Do u smoke after txt? Results of a randomised trial (2006) (1)
- Ischaemic Heart Disease. Background Paper 6.3. (2013) (1)
- Persistence with urate‐lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions (2022) (1)
- Polypills for the prevention of cardiovascular disease: a framework for wider use (2022) (1)
- A protocol for an economic evaluation of a polypill in patients with established or at high risk of cardiovascular disease in a UK NHS setting: RUPEE (NHS) study (2018) (1)
- Halving cardiovascular risk with combined blood pressure and cholesterol lowering - Why are we not there yet? (2021) (1)
- Multi-morbidity and blood pressure trajectories in hypertensive patients: A multiple landmark cohort study (2021) (1)
- Effect of dose administration aids on adherence to self-administered medications: a systematic review protocol (2019) (1)
- The pulmonary embolism prevention (PEP) trial: Effects of low-dose aspirin on major vascular events in patients with hip fracture (1999) (1)
- Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress (2022) (1)
- The Proportion of Dietary Salt Replaced With Potassium-Enriched Salt in the SSaSS: Implications for Scale-Up (2023) (1)
- A PRAGMATIC TRIAL OF A POLYPILL-BASED STRATEGY TO IMPROVE ADHERENCE TO INDICATED PREVENTIVE TREATMENTS AMONG PEOPLE AT HIGH CARDIOVASCULAR DISEASE RISK (2013) (1)
- Cardiovascular events with blood pressure lowering in patients with diabetes and systolic blood pressure below 140 mm Hg (2019) (1)
- A reply to comments by Lee and colleagues on: Repeated intranasal ketamine for treatment resistant depression – the way to go? Results from a pilot randomised controlled trial (2019) (1)
- P1943Ambient temperature and seasonal effects on blood pressure in 2.6 million Australians (2019) (1)
- Impact of various night-time period definitions on nocturnal ambulatory blood pressure (2022) (1)
- The value of risk assessment and burden of disease analyses. (2006) (1)
- Lost in translation: the gap between what we know and what we do about cardiovascular disease (2016) (1)
- OE-144 Perindopril-based Blood Pressure lowering Reduces Major Vascular Events in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischaemic Attack(Preventive medicine/Epidemiology/Education-1 (H) OE24,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the J (2006) (1)
- THE IMPACT OF CIGARETTE SMOKING ON CARDIOVASCULAR DISEASE AMONGST WOMEN AND MEN IN THE ASIA-PACIFIC REGION (2005) (1)
- Accumulating Evidence of Benefits From Intensive Blood Pressure Lowering: Are We There Yet? (2016) (1)
- Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality (2022) (1)
- A process for the treatment of pigmented cancer cells by photodynamic therapy (1998) (0)
- Cardiovascular preventive strategies are not conflicting (2020) (0)
- Table 4A.49, Risk factor: Physical inactivity: Disease: Diabetes mellitus (2006) (0)
- PO263 Choice In Blood Pressure Lowering Drug Therapy – An Analysis of the Availability of Different Drugs and Doses Over the Last 40 Years (2018) (0)
- Effects of Low-dose Triple Combination Therapy on Time at Target Blood Pressure – Results From the TRIUMPH Randomized Controlled Trial (2021) (0)
- Response to the letter from Korn et al (2008) (0)
- Combination pill for cardiovascular disease--reply. (2014) (0)
- Acute Increase in Creatinine after Starting ACE Inhibitor and Vascular Events and Premature Death in Patients with Type 2 Diabetes—The ADVANCE Trial (2018) (0)
- Impact of cardiovascular polypill based therapy on healthy lifestyle behaviour (2015) (0)
- P5732Effects of blood pressure lowering drugs in heart failure: a systematic review and meta-analysis of randomised controlled trials (2019) (0)
- Gems of New Zealand Primary Health Care Research: Increase in use of cardiovascular preventive medication (2010) (0)
- Changes in Albuminuria and the Risk ofMajor (2017) (0)
- A personalised or procrustean approach to treating hypertension? – Authors' reply (2017) (0)
- Effectiveness of a Sodium-Reduction Smartphone App and Reduced-Sodium Salt to Lower Sodium Intake in Adults With Hypertension: Findings From the Salt Alternatives Randomized Controlled Trial (2022) (0)
- RESTING HEART RATE AND THE RISK OF DEATH AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: 7E.03 (2011) (0)
- Reply to J-P Chaput (2011) (0)
- EDITORIAL Measuring Mäori health status accurately - more needs doing Tony Blakely, (2002) (0)
- Optimising TRIUMPH with 6·25 mg chlorthalidone - Authors' reply. (2020) (0)
- Bloodpressure andriskof stroke inpatients with cerebrovascular disease (1996) (0)
- Why is there more heat than light concerning the polypill? (2008) (0)
- Reply: Personalization of therapy and polypills (2014) (0)
- Table 45.6, Polypill Cost-Effectiveness Estimates for a Population of 1 Million Adults at Varying Levels of Risk for CVD Treated for 10 Years in India (2006) (0)
- Cumulative Systolic Blood Pressure Load and Risk of Cardiovascular Outcomes in Patients With Diabetes (2022) (0)
- Blood pressure, cholesterol and cardiovascular diseases in eastern Asia. (2001) (0)
- Cost-effectiveness analysis of initial treatment with single-pill combination antihypertensive medications (2023) (0)
- 2 PreventCVD : protocol for a systematic review and individual participant data meta-analysis of text message-based interventions for the prevention of cardiovascular diseases (2016) (0)
- PEP trial (2000) (0)
- Abstract 13354: Effectiveness of a Complex Intervention Based on Electronic Decision Support to Improve Management of Cardiovascular Disease Risk in Primary Healthcare: A Cluster-randomised Controlled Trial (2020) (0)
- PS 14-28 EFFICACY AND SAFETY OF COMBINATION OF THREE OR MORE BP LOWERING DRUGS FOR THE MANAGEMENT OF HIGH BLOOD PRESSURE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (2016) (0)
- P1587Comparison of effects of lowering blood pressure in individuals with blood pressure <140/90 mmHg and hypertension guideline recommendations: a systematic review and meta-analysis of randomised trials (2019) (0)
- Breast screening (1989) (0)
- PS-BPC07-7: REDUCED EFFICACY OF BLOOD PRESSURE LOWERING DRUGS IN THE PRESENCE OF DIABETES MELLITUS: RESULTS FROM THE TRIUMPH RANDOMISED CONTROLLED TRIAL. (2023) (0)
- 060 The Effects of Combination Blood Pressure Lowering in the Presence or Absence of Background Statin and Aspirin Therapy – a Combined Analysis of PROGRESS and ADVANCE (2020) (0)
- Blood pressure and cardiovascular disease in the Asia Pacific region (2007) (2007) (0)
- 471 Cumulative Benefits of Cholesterol Lowering for the Prevention of Cardiovascular Events (2020) (0)
- Abstract 16361: Effects of Low-dose Triple Combination Therapy on Time at Target Blood Pressure - Results From the TRIUMPH Randomized Controlled Trial (2020) (0)
- cardiovascular disease acceptability of a polypill for prevention of Process evaluation of the impact and and (2015) (0)
- 057 Regression to the Mean in Home Blood Pressure: Analyses of the BP GUIDE Study (2020) (0)
- Wisdom of the Crowd: insights gained from comparing predicted and observed effects of blood pressure lowering strategies (2023) (0)
- 3.1 Stroke, coronary heart disease, cholesterol and blood pressure (1997) (0)
- EFFECTS OF SALT SUBSTITUTES ON BLOOD PRESSURE AND CLINICAL OUTCOMES IN DIFFERENT POPULATION GROUPS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2022) (0)
- EFFECTS OF BLOOD PRESSURE LOWERING DRUGS IN HEART FAILURE (2019) (0)
- Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (2021) (0)
- BLOOD PRESSURE AND TREATMENT PATTERNS BY SEASON IN AUSTRALIAN PRIMARY CARE: AN ANALYSIS OF THE MEDICINEINSIGHT DATABASE (2020) (0)
- More Intensive LDL-C Lowering Reduces Major Vascular Events Beyond Current Recommendations: Systematic Review and Meta-Analysis (2019) (0)
- Efficacy and Safety of Low-Dose Triple and Quadruple Combination Pills vs Monotherapy, Usual Care, or Placebo for the Initial Management of Hypertension: A Systematic Review and Meta-analysis. (2023) (0)
- ADVANCE Master Meeting I of the ADVANCE Glucose-Lowering Arm (2008) (0)
- Epidural Steroid Injections for Sciatica and Back Pain a Meta-Analysis of Controlled Clinical Trials (1996) (0)
- Evaluation of the ability of a commercially available cuffless wearable device to track blood pressure changes (2023) (0)
- Concise review: the polypill in cardiovascular disease prevention (2007) (0)
- British Medical Journal (1917) (0)
- Abstract P445: A Randomized Controlled Trial Of A Cardiovascular Fixed-dose Combination Pill (polypill) Treatment Strategy Compared With Usual Care On Carotid Intima Media Thickness Progression In Individuals At High Risk Of Cardiovascular Disease (2014) (0)
- ANALYSIS & COMMENTARY Applying A 3.0 Transformation Framework To Guide Large-Scale Health System Reform (2014) (0)
- Cost-effectiveness ofTobacco Exercise and diet MEssages(TEXT ME), a text message-based intervention for secondary prevention of cardiovascular disease (2017) (0)
- False reassurance about the consequences of withdrawing antihypertensive drug therapy. (2018) (0)
- Pregnancy and leg ulceration. (2004) (0)
- Author Index / Subject Index Vol. 4 (suppl 1) 1994 (1994) (0)
- Blood pressure and cardiovascular disease in the Asia Pacific region (Chinese Journal of Cardiology) (2006) (0)
- Macrophage responses and their involvement in generating an immune response against tuberculosis. (2003) (0)
- Clinical Utility of Short-Term Blood Pressure Measures to Inform Long-Term Blood Pressure Management (2022) (0)
- 021 Effects of Low-dose Triple Combination Therapy on Therapeutic Inertia and Prescribing Patterns in Hypertension – Results from the TRIUMPH Trial (2020) (0)
- Association between comorbidities and blood pressure trajectories in patients with hypertension (2020) (0)
- Abstract P201: Canagliflozin, Visit-to-visit Blood Pressure Variability, And Risk Of Cardiovascular, Kidney, And Mortality Outcomes: Pooled Individual Participant Data From The CANVAS And CREDENCE Trials (2022) (0)
- Table 4A.15, Risk factor: Vitamin A deficiency: Disease: Other infectious diseases (2006) (0)
- Systematic review – Protocol (2015) (0)
- Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology 11 Medica (2018) (0)
- Effect of chitosan on body-weight is clinically negligible (2005) (0)
- A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP‐HEPC trial) (2021) (0)
- Brest Cancer Screening—An Alternative View Point (1990) (0)
- The appropriate roles of audit and randomisation in determining the efficacy of anaesthetic interventions (1995) (0)
- The occurence of leg ulcers in Auckland: Results of a population of a population-based study (2002) (0)
- Emballage de formulations d'adhesifs thermofusibles a faible temperature d'application (2001) (0)
- Table 4A.51, Risk factor Physical inactivity: Disease: Cerebrovascular disease (2006) (0)
- The National Lottery could provide a unique and important randomised trial (2020) (0)
- Does splitting a tablet obtain an accurate dose? A systematic review and meta‐ analysis (2022) (0)
- TV watching: Feasibility of an intervention to decrease TV watching in children (2010) (0)
- Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE Trials (2021) (0)
- P2-148 Psychological functioning and health related quality of life in adulthood following preterm birth (2007) (0)
- Title Long-term effects of antenatal betamethasone on lung function : 30 year follow-up of a randomised controlled trial (2006) (0)
- Compositions for the treatment of hypertension (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Anthony Rodgers?
Anthony Rodgers is affiliated with the following schools:
